APA (7th ed.) Citation

Govoni, M., Bassi, M., Girardello, L., Lucci, G., Rony, F., Charretier, R., . . . Watz, H. (2024). CHF6523 data suggest that the phosphoinositide 3-kinase delta isoform is not a suitable target for the management of COPD. Respiratory research, 25, . https://doi.org/10.1186/s12931-024-02999-5

Chicago Style (17th ed.) Citation

Govoni, Mirco, et al. "CHF6523 Data Suggest That the Phosphoinositide 3-kinase Delta Isoform Is Not a Suitable Target for the Management of COPD." Respiratory Research 25 (2024). https://doi.org/10.1186/s12931-024-02999-5.

MLA (9th ed.) Citation

Govoni, Mirco, et al. "CHF6523 Data Suggest That the Phosphoinositide 3-kinase Delta Isoform Is Not a Suitable Target for the Management of COPD." Respiratory Research, vol. 25, 2024, https://doi.org/10.1186/s12931-024-02999-5.